Newly detected atrial fibrillation and compliance with antithrombotic guidelines - Wikidata - wikimedia - TriplyDB

Newly detected atrial fibrillation and compliance with antithrombotic guidelines

Newly detected atrial fibrillation and compliance with antithrombotic guidelines

http://www.wikidata.org/entity/Q28218990

about

Anticoagulation for atrial fibrillation in patients on dialysis: are the benefits worth the risks?A systematic review of validated methods for identifying atrial fibrillation using administrative data Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation.2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.Untreated atrial fibrillation in the United Kingdom: Understanding the barriers and treatment options Association of body mass index, diabetes, hypertension, and blood pressure levels with risk of permanent atrial fibrillation Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation.Atrial fibrillation and risk of dementia: a prospective cohort study.Erratum: utilization of anticoagulation therapy in medicare patients with nonvalvular atrial fibrillation Ascertainment of warfarin and aspirin use by medical record review compared with automated pharmacy data.A review of the safety of anticoagulants in older people using the medicines management pathway: weighing the benefits against the risks Predictors of warfarin use in atrial fibrillation in the United States: a systematic review and meta-analysis.Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis.Long-term outcomes following development of new-onset atrial fibrillation during sepsis A cluster-randomized controlled trial of a computerized antithrombotic risk assessment tool to optimize stroke prevention in general practice: a study protocol.Neighborhood deprivation and warfarin, aspirin and statin prescription - A cohort study of men and women treated for atrial fibrillation in Swedish primary care.Differences in anticoagulant therapy prescription in patients with paroxysmal versus persistent atrial fibrillation.Oral Anticoagulant Prescription in Patients With Atrial Fibrillation and a Low Risk of Thromboembolism: Insights From the NCDR PINNACLE Registry Adherence to oral anticoagulants in patients with atrial fibrillation-a population-based retrospective cohort study linking health information systems in the Valencia region, Spain: a study protocol.Inflammation as a Mediator of the Association Between Race and Atrial Fibrillation: Results from the Health, Aging, and Body Composition Study.Beneficial effects of stroke-unit care in stroke patients with atrial fibrillation.Effect of race on outcomes (stroke and death) in patients >65 years with atrial fibrillation.Heart failure performance measures: eligibility and implementation in the community.The use of anticoagulants in the management of atrial fibrillation among general practices in England Dabigatran, A Direct Thrombin Inhibitor, In Atrial Fibrillation: Is It Already Time For A Change In Oral Anticoagulation Therapy?Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study The risk of atrial fibrillation in patients with rheumatoid arthritis Five years of keeping a watch on the left atrial appendage-how has the WATCHMAN fared?Paroxysmal supraventricular tachycardia and the risk of ischemic stroke Inappropriate combination of warfarin and aspirin Dabigatran etexilate, a new oral direct thrombin inhibitor, for stroke prevention in patients with atrial fibrillation.Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation.Underuse of antithrombotic therapy caused high incidence of ischemic stroke in patients with atrial fibrillation.Anticoagulation bridging around device surgery: compliance with guidelines.Misperceptions of aspirin efficacy and safety may perpetuate anticoagulant underutilization in atrial fibrillation.Risk of incident atrial fibrillation in gout: a cohort study.Utilization of antithrombotic therapy for stroke prevention in atrial fibrillation: a cross-sectional baseline analysis in general practice.Atrial fibrillation and ethnicity: the known, the unknown and the paradox.Warfarin treatment and risk of stroke among primary care patients with atrial fibrillation.Shared decision making for stroke prevention in atrial fibrillation: study protocol for a randomized controlled trial.

P2860

Q27010464-8852FF8B-B1E7-4752-836C-71DC7918ED62 Q27026830-FAF22C4D-F629-4C2A-B2E2-ADE04600583D Q27311041-81D73761-D707-4355-BC37-4F144B5F3B8B Q27341873-685F6936-9A06-43C6-85ED-77CD5B984BD4 Q28081837-18F29CC3-EA42-4EB8-926D-082D2A320D4C Q28709414-6597493B-B10A-44E7-8FB4-D65F159AB4C0 Q30371014-2AA6BF4A-347D-41B3-8D3D-17EB796672C2 Q30505985-36F0A20B-E6D0-4CA5-8980-9F052B4D993D Q33714864-F70198A8-81D6-4C56-8206-D53BA159453C Q33829782-F9B03289-B780-4DBB-B9FF-C3A10187D20E Q33949244-7ED9F230-DF55-42A9-A6AA-D3820EC61120 Q34150474-2E83B7E8-55C6-417B-AFCC-28FCC09138C8 Q34232375-D78B7598-E85F-4A6C-8399-96D362CDB591 Q34448321-526AE536-8225-4296-9273-770F9AC1A2EC Q35089113-7FD94E7C-3773-4671-B52A-E649CC1B7670 Q35639707-0238EC3B-7CE2-4C75-9908-C4F0ACC885BF Q35966775-E95DEE17-A58F-447E-9823-2E3D426D91A5 Q35966802-59E8E4B8-D024-471F-9071-C31EEF679374 Q36179688-F3346C66-A0D5-4B10-A82C-ABAF93D4BE41 Q36185363-7B013350-183B-4254-AF72-D4D3000AD779 Q36620437-8A2F9FA3-F03B-4A58-B4B4-B44DEC892F32 Q36657968-7FF70819-CBE7-4C05-B071-20F418AFF878 Q36981702-93223945-141C-4DF1-B4EE-F0BFDD62BB79 Q37030961-02DD8909-A2E4-41BC-8A5D-3E61B0629553 Q37115353-2A8F9E98-7890-4BCE-B965-A7307A25CFE6 Q37288459-0AD8957F-5E9F-4081-8A21-8E31EFAD9C0B Q37446317-22073DC1-DCEF-4575-9E10-29728DA6C5EB Q37581151-A2779AB2-E786-4B99-8D2A-8333C6181A50 Q37631671-3D1A27DA-2F49-4B6F-AF8C-DA84CD5F1EE7 Q37680357-652F86BA-D71C-4EF6-B80A-55ECBE7A5A09 Q37743508-F14CBF1E-174D-415E-89DA-2DE558336D20 Q37870757-C62AB0AD-C70A-4697-92E9-38203EE03F23 Q37959031-843121A2-76C1-479C-AFA0-986DE6B123ED Q38043562-98E563AD-BBE3-41C0-957D-7807A81A43B4 Q38303442-02E3AAF2-8857-4318-93C8-6AA72A2E718E Q38732470-6FCA8D19-EF44-4056-89CD-BE15E4AB7D66 Q39659827-D5776C6A-9F8C-44B4-8664-C158DEAB682A Q39932702-9C40F2B3-10DB-4A7A-9716-D1FECBA84704 Q41657202-98BAE4A0-83D6-4135-998A-729DD0C5A36C Q41997375-57FC40E9-EE2A-494C-A6E2-2A3E5161C7A8

P2860

Newly detected atrial fibrillation and compliance with antithrombotic guidelines

http://www.wikidata.org/entity/Q28218990

description

2007 nî lūn-bûn

@nan

2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Newly detected atrial fibrillation and compliance with antithrombotic guidelines

@ast

Newly detected atrial fibrillation and compliance with antithrombotic guidelines

@en

Newly detected atrial fibrillation and compliance with antithrombotic guidelines

@nl

type

label

Newly detected atrial fibrillation and compliance with antithrombotic guidelines

@ast

Newly detected atrial fibrillation and compliance with antithrombotic guidelines

@en

Newly detected atrial fibrillation and compliance with antithrombotic guidelines

@nl

prefLabel

Newly detected atrial fibrillation and compliance with antithrombotic guidelines

@ast

Newly detected atrial fibrillation and compliance with antithrombotic guidelines

@en

Newly detected atrial fibrillation and compliance with antithrombotic guidelines

@nl

P1433

Q28218990-A54CBBFC-D239-4A7C-A968-6F2B110130B4

P1476

Q28218990-9465AB55-E47B-4FBD-BBAC-C097EF35A0BC

P2093

Q28218990-10E6B782-E8B5-46A5-B73D-68A4FF69D3EE

Q28218990-16D15105-2EA0-4D71-8A0D-D4CCBF957D4A

Q28218990-190E85E6-CA09-4B0E-9D94-05A8238694F1

Q28218990-8461A236-6C02-424C-888C-A6C8B16FBD21

Q28218990-8B601811-6997-493C-878F-40C3D7FA821E

Q28218990-ECBA8397-23ED-4062-BD37-CD8E83078584

P304

Q28218990-635FA443-22B5-4AE6-BA4A-246A1819DC3B

P31

Q28218990-22A6AE2F-530A-4DB1-825F-B975C898D36A

P356

Q28218990-37C44EDC-9C39-4F3C-8220-95C04277FF26

P407

Q28218990-FECFAAD3-9A26-4720-A3D8-A7F6097C7F54

P433

Q28218990-C45F8CDF-5EAA-43EA-99F2-4F1657022C3C

P478

Q28218990-AF2957F8-4484-4ED7-B748-8C7C0C18F19E

P50

Q28218990-1923A3BB-D29D-4674-8F97-A20921B0FCD9

Q28218990-547A29E5-AC1C-46EB-9185-2D78BEE43C96

Q28218990-8D07440F-6068-42A3-99E8-47EDCCF02D26

P577

Q28218990-100AB920-3A98-4715-9AC1-D00FD947E14F

P698

Q28218990-43B12F27-67AB-4F53-97DB-0081D6FD77AC

P921

Q28218990-25BEE146-4004-45BA-B3C9-40DA1710BF9D

P356

ARCHINTE.167.3.246

P1433

JAMA Internal Medicine

P1476

Newly detected atrial fibrillation and compliance with antithrombotic guidelines

@en

P2093

Benjamin French

http://www.w3.org/2001/XMLSchema#string

Jennifer B Hrachovec

http://www.w3.org/2001/XMLSchema#string

Lisa A Jackson

http://www.w3.org/2001/XMLSchema#string

Nicholas L Smith

http://www.w3.org/2001/XMLSchema#string

Nicole L Glazer

http://www.w3.org/2001/XMLSchema#string

Sascha Dublin

http://www.w3.org/2001/XMLSchema#string

P304

246-52

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHINTE.167.3.246

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

167

http://www.w3.org/2001/XMLSchema#string

P50

David S Siscovick

Susan R Heckbert

P577

2007-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17296879

http://www.w3.org/2001/XMLSchema#string

P921

atrial fibrillation